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Introduction
Pelvic inflammatory disease (PID) and metritis are
important causes of serious disease and infertility in
humans and domestic animals. Each year in the USA,
more than one million women experience an episode
of acute PID, more than 100,000 become infertile as a
result and more than 150 women die from PID or its
complications.1 Metritis affects 40% of dairy cattle
after parturition, with each case costing an estimated
$250 for reduced milk production, delayed conception
and treatment.2 Much of the infertility following a
case of PID or metritis is associated with damage to
the genital tract and reduced embryo survival.3–5
However, there is increasing evidence that uterine
disease also affects ovarian function.
Metritis is associated with slower growth of the
dominant follicle in the ovary, fewer ovulations
and lower peripheral plasma estradiol concentrations
compared with clinically normal cattle.6–8 The most
numerous pathogenic bacterium in the bovine
uterus is Escherichia coli and its presence is specifically
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Problem
Pelvic inflammatory disease and metritis are important causes of infertil-
ity in humans and domestic animals. Uterine infection with Escherichia
coli in cattle is associated with reduced ovarian follicle growth and
decreased estradiol secretion. We hypothesized that this effect could be
mediated by the bacterial lipopolysaccharide (LPS) or cytokines such as
tumour necrosis factor alpha (TNFa).
Method of study
In vitro, bovine ovarian theca and granulosa cells were treated with LPS
or TNFa and steroid secretion measured. In vivo, the effect of LPS or
TNFa intrauterine infusion was determined by ovarian ultrasonography
and measurement of hormones in cattle.
Results
Lipopolysaccharide reduced granulosa cell estradiol secretion, whilst
TNFa decreased theca and granulosa cell androstenedione and estradiol
production, respectively. In vivo, fewer animals ovulated following intra-
uterine infusion with LPS or TNFa.
Conclusion
Lipopolysaccharide and TNFa suppress ovarian cell function, supporting
the concept that pelvic inflammatory disease and metritis are detrimen-
tal for bovine ovarian health.
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associated with ovarian dysfunction.8 The effects of
E. coli are likely mediated directly through the endo-
toxin, lipopolysaccharide (LPS), or indirectly through
the inflammatory mediators associated with E. coli
infection including cytokines such as tumour necrosis
factor alpha (TNFa).9 Indeed, there are increased
concentrations of LPS and TNFa in the peripheral
plasma of animals with uterine infection.6,8,10,11
More importantly, LPS concentrations are increased
in the ovarian follicular fluid of animals with uterine
disease.12
Studies exploring the effect of LPS on reproductive
biology in the whole animal have focused on sup-
pression of gonodotrophin releasing hormone
(GnRH) and luteinising hormone (LH) from the
hypothalamus and pituitary, respectively, rather than
on ovarian follicle function.13–15 However, in sheep,
there is evidence that LPS was associated with
reduced estradiol secretion independently of LH pulse
secretion.16 There is in vitro evidence that theca and
granulosa cell function may be perturbed by LPS in
the rat.17 Ovarian granulosa cells express the innate
immune receptor complex for detection of LPS,
and treatment with LPS modulates their endocrine
function.12 Alternatively, cytokines associated with
uterine inflammation may affect ovarian function as
they appear to suppress ovarian cell steroidogenesis,
although serum-free culture methods were not
always used in previous experiments.18,19
In the present study, cattle have been used to
investigate the effect of uterine disease on ovarian
function because the disease is biologically relevant
and granulosa cells can be isolated free of immune
cell contamination.12 Furthermore, unlike humans,
ovarian tissue is readily available from normal
animals post-mortem and intervention studies can
readily be preformed in vivo.20,21 We use pure popu-
lations of ovarian cells in vitro and uterine infusion
in vivo to test the hypothesis that LPS directly, or
indirectly via TNFa, perturbs ovarian function.
Materials and methods
In vitro Study
Granulosa and theca cell culture
Granulosa cells were obtained and cultured sepa-
rately in serum-free medium as previously
described.12,22 Briefly, bovine ovaries were collected
at a local abattoir immediately post-mortem and
returned to the laboratory within 1 hr. Follicles were
isolated manually by dissection and selected for iso-
lation of cells if they had a translucent appearance, a
well-vascularized theca and clear follicular fluid with
no visible debris or blood. Follicles were measured
using a grid or calipers and classed by external diam-
eter as small (<4 mm diameter), medium (4–8 mm
diameter) or large (>8 mm diameter), reflecting their
gonadotropin dependence and changes in the
expression of steroidogenic enzymes and LH recep-
tors.23,24 At 4 mm diameter, follicles are recruited
into follicle waves in cattle and become responsive
to follicle stimulating hormone (FSH), with increased
expression of aromatase.25 From 8 mm diameter,
granulosa cells express LH receptors and these
selected dominant follicles require pulsatile LH stim-
ulation to continue growing.25 Follicles were cut in
half and granulosa cells obtained by flushing the
hemisected shells and collecting the cell-rich super-
natant.22 Theca cells were then obtained by manu-
ally peeling the basal lamina from the hemisected
follicular shells and digesting the tissue in M199
(Sigma, Dorset, UK) containing 1 mg ⁄mL collagenase
(Sigma) and 100 lg ⁄mL trypsin inhibitor, in a mov-
ing water bath for 45 min at 37C and collecting the
cell-rich supernatant.26
As determined by Trypan Blue exclusion, granu-
losa and theca cells were >80% viable and were
seeded separately in 96-well plates (Nunc) at
1.5 · 106 cells ⁄mL. Cells were incubated at 37C in a
5% CO2 atmosphere in serum-free medium, with
granulosa cell medium supplemented with 10)7 m
androstenedione.22
After an initial 48-hr establishment period, cell
culture media was removed and replaced with fresh
media containing treatments. In the first experiment,
cells were treated with medium containing either 0,
0.1, 1, or 10 lg ⁄mL LPS (E.coli serotype 055.B5;
Sigma). These concentrations are similar to the con-
centrations of LPS in the follicular fluid of animals
with clinical disease and are also similar to concen-
trations of LPS used in previous studies to explore
immune cell function.12,27–29 In a further experi-
ment, cells were treated with 0, 1, 10, or 100 ng ⁄mL
TNFa, as these concentrations have been shown to
affect steroidogenesis.18 The media were changed
after 48 hr and then collected at 96 hr to identify
any longer term effects on ovarian cell steroidogene-
sis, reflecting the whole animal clinical context.7,8 At
the end of the incubation period, the number of via-
ble cells was determined by neutral red dye uptake,
as previously described.30
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Hormone Assays
Culture supernatants were analyzed by radioimmu-
noassay as previously described,31 adapted for estra-
diol or androstenedione. Samples were diluted in
0.05 m Tris buffer containing 0.1% gelatin and 0.01%
sodium azide. Standards, antiserum and tritiated
tracer were purchased from Sigma (UK), Biogenesis
(UK) and Amersham International PLC (Amersham,
UK), respectively. The limits of detection were
80 pg ⁄mL for estradiol and 50 pg ⁄mL for androstene-
dione. The respective intra- and inter-assay coeffi-
cients of variation were 8.8% and 9.9% for estradiol
and 3.1% and 12.6% for androstenedione.
In vivo Study
Animals
Eight nulliparous post-pubertal Holstein heifers aged
between 13 and 15 months at the start of the study
were assigned to control or treatment groups in a
randomized crossover design (n = 8 per treatment).
Animals were housed in a straw-bedded yard in a
naturally ventilated shed and fed a diet formulated
according to standard guidelines.32 The diet com-
prised ad libitum grass hay and concentrates (Grow-
ergrain Nuts; BOCM Pauls Ltd, Ipswich, UK) and the
animals had ad libitum access to water. To limit any
influence of infectious disease, the heifers were
tested free of bovine viral diarrhoea (BVD), Leptospi-
rosis, bovine herpes virus-1 (BHV-1), Tuberculosis,
Brucella and enzootic bovine leukosis (EBL) before
experiments began. Maiden heifers were chosen for
the study as they were predicted to have a sterile
uterine environment, which was confirmed by regu-
lar uterine bacterial swabs, collected as previously
described.33 No bacteria were isolated from any of
the animals at any point during the study. In addi-
tion, before the study began, the heifers were clini-
cally assessed to ensure normal reproductive
anatomy and ovarian function, and animals were
acclimatized to the handling and housing facilities
for 3 weeks. All procedures were carried out under
Home Office authorization in compliance with the
Animals (Scientific Procedures) Act 1986 and experi-
mental protocols were approved by the Royal Veteri-
nary College Ethical Review Committee.
The experimental protocol was as previously
described.34 Briefly, oestrus cycles were synchro-
nized in the heifers by two intramuscular injections
of a prostaglandin F2a analogue (cloprostenol, Estru-
mate, Scherring Plough Animal Health) 11 days
apart [prostaglandins (PG1 and PG2)]. For 3 days
following the PG2 injection, animals were observed
for 30 min every 2 hr to detect oestrus, as deter-
mined by the first time an animal stood to be
mounted. On the morning of the seventh day after
first observed standing oestrus, each heifer was given
a third injection of prostaglandin F2a analogue (PG3)
to induce luteal regression and permit ovulation of
the expected dominant follicle.
Treatments
In the first experiment investigating the effects of
LPS, animals were randomly administered a control
infusion of 10 mL sterile phosphate-buffered saline
(PBS) or 10 mL sterile PBS containing 3.0 lg ⁄kg
E. coli serotype 055:B5 LPS (Sigma-Aldrich). In the
second experiment investigating the effects of TNFa,
animals were randomly administered a control infu-
sion of 10 mL sterile PBS, or 10 mL sterile PBS con-
taining 0.1 lg rhTNFa (Sigma-Aldrich). Treatments
were administered in a crossover design such that
each animal received both control and LPS treat-
ments in the first experiment, followed by control
and TNFa treatments in the second experiment, with
a recovery period of one spontaneous oestrous cycle
between treatment periods to minimize carry-over
effects from the previous treatment.
Infusions began 24 hr after first observed standing
oestrus following PG2 and were administered every
6 hr for 9 days. Infusions were carried out by passing
a sterile, disposable bovine uterine catheter (Arnolds,
Shropshire, UK) through the cervix and into the uter-
ine lumen guided by transrectal palpation. The treat-
ment was drawn into a sterile 10-mL syringe (BD,
Oxford, UK) which was then attached to the end of
the catheter and the contents infused into the uterus.
Clinical Examination
Reproductive function was monitored as previously
described.7,8 Briefly, the genital tract of each cow
was examined by transrectal palpation and ultraso-
nography using a 7.5-MHz linear array transducer
(Honda HS-2000; Honda Electronics, Aichi, Japan).
Ovarian follicles ‡4 mm in diameter and corpora lu-
tea in each ovary were identified and the maximum
diameter of each structure was estimated by averag-
ing measurements made using the instrument’s inter-
nal calipers in two dimensions at 90.7,35 A follicle
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was defined as a non-echogenic structure with a
clear demarcation between the follicular wall and
the antrum; and, the day of dominance was defined
as the day the largest follicle on the ovary achieved
an internal diameter of ‡8.5 mm, which corresponds
to the onset of deviation.36 The day of ovulation was
classed as the last day a dominant follicle was
scanned before it disappeared and a corpus luteum
(CL) subsequently formed in its place.35 A CL was
characterized by a grainy echogenic structure with a
well-defined border within the ovarian stroma, often
with a non-echogenic lacuna.
General health was monitored every 6 hr through-
out the study period, including measurement of rec-
tal temperature using a standard digital thermometer
(National Veterinary Supplies, Stoke-on-Trent, UK).
Body weight was estimated using a proprietary
weigh-band (Ascott Ltd, Powys, UK) placed around
the chest and shoulder area. Body condition was
scored by visual assessment and palpation of areas of
each animals body and assigning a score based on
the fat distribution.37
Blood Sample Collection and Analysis
Blood samples were collected at regular intervals
from the jugular vein. Blood samples were collected
following PG2 every 3 hr for 6 days, every 12 hr for
5 days and finally every 3 hr until the end of the
study. In the LPS experiment, only blood samples
were collected via jugular catheter every 12 min
during an 8-hr time period. This allowed measure-
ment of pulsatile LH release from the pituitary as
there is evidence that LPS can suppress LH pulsatili-
ty.13
Plasma concentrations of estradiol were analyzed
using the Estradiol MAIA radioimmunoassay kit
(Biogenesis, Poole, UK) by the method previously
described by Prendiville et al.,38 with some modifica-
tions as described by Williams et al.8 The intra- and
inter-assay coefficients of variation were 20.8 and
21.6%, respectively and the sensitivity was
0.24 pg ⁄mL. Plasma concentrations of progesterone
were measured in duplicate using a commercial
ELISA kit (Ridgeway Science, Gloucester, UK) fol-
lowing the manufacturers guidelines. The intra- and
inter- assay coefficients of variation were 2.7 and
12.2%, respectively and the sensitivity was
0.6 ng ⁄mL.
The concentrations of LH and FSH were measured
in duplicate in peripheral plasma as described previ-
ously.35 Standards were purchased from the National
Hormone and Pituitary Programme (NHPP, CA,
USA) and iodinated tracers were purchased from
Amersham International PLC (Amersham, UK). For
FSH, the internal recovery was 95%, the intra-assay
coefficient of variation was 14.0% and the inter-
assay coefficient of variation was 10.5%. For LH,
internal recovery was 95%, the intra-assay coeffi-
cient of variation was 14.0% and the inter-assay
coefficient of variation was 10.4%. LH concentra-
tions were analyzed using the computer algorithm
pulsar to determine the mean, maximum and mini-
mum LH concentrations, number of pulses, mean
pulse amplitude, mean pulse length, mean frequency
and mean inter-pulse interval.39 The onset of LH
peak was defined as the time at which LH concen-
tration exceeded 5 ng ⁄mL.
Concentrations of the acute phase protein a1-acid
glycoprotein were measured using a previously
described method adapted for 96-well plates (Life
Technologies, Invitrogen, Renfrew, UK).40,41 The
intra-assay and inter-assay coefficients of variation
were 12 and 18%, respectively and the sensitivity
was 0.2 mg ⁄mL.
Statistical Analysis
All data were analyzed using the statistics program
sas 9.1.42 Results are reported as the arithmetic
mean ± S.E.M., and significance ascribed when
P < 0.05. The effects of treatments in vitro were
explored using Mixed Model anova as described pre-
viously.7 In vivo data were normalized to first day of
uterine infusion, which was defined as day 0. Data
from control and treated animals were compared by
anova and post hoc tests performed with Dunnet’s
adjustment, except for proportions, which were
compared using the Fisher exact test.
Results
Effect of LPS on Ovarian Cell Function in vitro
Treatment with LPS did not affect cell numbers or
androstenedione production by theca cells isolated
from small, medium or large ovarian follicles
(Fig. 1a). However, LPS treatment decreased estra-
diol production by granulosa cells isolated from small
(P < 0.001: mixed model analysis), medium
(P < 0.001), or large (P < 0.001) ovarian follicles
(Fig. 1b).
LPS AND TNFa AFFECT OVARIAN FUNCTION
American Journal of Reproductive Immunology 60 (2008) 462–473 ª 2008 The Authors
Journal compilation ª 2008 Blackwell Munksgaard 465
Effect of TNFa on Ovarian Cell Function in vitro
Treatment with TNFa reduced androstenedione pro-
duction by theca cells isolated from all follicle sizes
despite increasing the number of cells in some cases
(P < 0.001; Fig. 2a). In addition, TNFa suppressed
estradiol production by granulosa cells isolated from
small (P < 0.01), medium (P < 0.001), and large
(P < 0.01) ovarian follicles supplied with 10)7m
androstenedione. Granulosa cell numbers were not
affected by TNFa (Fig. 2b).
In vivo Studies
In the LPS and TNFa studies, rectal temperatures
were consistently within the normal range of 38.0–
38.5C during each study period, and peripheral
concentrations of the acute phase protein alpha-1
acid glycoprotein (AGP) were not different between
treatments. In the LPS study, AGP concentrations
ranged from 0.07 to 2.25 mg ⁄ml and from 0.04 to
2.28 mg ⁄mL for control and treated animals, respec-
tively. In the TNFa study, AGP concentrations ran-
ged from 0.30 to 4.35 mg ⁄mL and from 0.33 to
4.34 mg ⁄mL for control and treated animals, respec-
tively. One animal was removed prior to the TNFa
study because of an unrelated clinical disease.
All animals had an active corpus luteum at the
time of induction of luteolysis (PG2), as determined
by ultrasonography and peripheral plasma progester-
one concentrations >1 ng ⁄mL, displayed standing
estrus and the dominant follicle ovulated. An LH
surge was observed at the time of first standing oes-
trus ±6 hr and there was no significant difference
between treatment groups. Similarly, FSH concentra-
tions did not differ between treatment groups
(Fig. 3).
Effect of LPS on Ovarian Function in vivo
Following oestrus, a new wave of ovarian follicles
emerged in all animals and dominant follicle diame-
ter increased over time (P < 0.001). No significant
differences were observed in dominant follicle diam-
eter or estradiol concentrations between treated and
control animals (Fig 4). Plasma progesterone concen-
trations increased over time (P < 0.001) concomitant
with formation of the CL after oestrus in all animals
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(Fig. 5a(i)). Progesterone concentrations were lower
in animals treated with LPS between days 3 and 9
(P < 0.05: mixed model analysis). A prostaglandin
F2a analogue injection was administered on day 6 to
permit ovulation of the new dominant follicle (PG3),
but fewer LPS-treated animals did ovulate (3 ⁄8 ver-
sus 7 ⁄8, P < 0.05).
Following PG3, pulsatile LH secretion was
observed in all animals and no difference in mean,
maximum, or minimum LH concentrations was
observed between LPS or control treatments. The
number of peaks observed was the same for each
treatment and there was no difference in peak
amplitude, peak frequency, peak length, or inter-
peak interval between treatments (Table I). Repre-
sentative patterns of pulsatile LH secretion during
the control or LPS infusion are shown in Fig. 6.
Effect of TNFa on Ovarian Function in vivo
Following oestrus, a new wave of ovarian follicles
emerged in all animals and as expected, dominant
follicle diameter increased over time (P < 0.001).
Dominant follicle diameter and plasma estradiol
concentrations did not differ significantly between
treatments (Fig. 4). Plasma progesterone concentra-
tions increased over time (P < 0.001) concomitant
with formation of the CL after oestrus in all animals,
but did not differ significantly between treatments
(Fig. 5). A prostaglandin F2a analogue injection was
administered on day 6 to permit ovulation of the
new dominant follicle (PG3), but fewer animals ovu-
lated when treated with TNFa as compared with
control (4 ⁄7 versus 6 ⁄7, P = 0.09).
Following PG3, an LH surge was observed in all
animals at the time of oestrus ±9.1 hr (correspond-
ing to 41.4 ± 1.7 hr after PG3); LH concentration
was 14.1 ± 1.7 ng ⁄mL with no significant difference
between control and TNFa treatment.
Discussion
Animals with metritis, particularly those associated
with E. coli infection, have reduced ovarian follicle
growth and function and are less likely to ovu-
late.7,8,43 These effects could be mediated directly by
E. coli LPS or indirectly by cytokines such as TNFa in
response to uterine infection. In this study, ovarian
cell steroidogenesis was inhibited by treatment with
LPS or TNFa in vitro. Granulosa cell estradiol secre-
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tion was reduced by LPS treatment, whilst TNFa
reduced theca and granulosa cell androstenedione
and estradiol production, respectively. The effects of
LPS or TNFa on ovarian function were more subtle
in vivo when infused into animals during a defined
period of ovarian follicle and corpus luteum develop-
ment. However, the dominant follicle formed during
LPS or TNFa treatment was less likely to ovulate
than in control animals. Taken together, these stud-
ies support the hypothesis that LPS or TNFa can
directly impair ovarian function. Thus, it is impor-
tant for clinicians treating patients with PID or me-
tritis to be aware that uterine infection can affect
ovarian as well as uterine health.
Microbial infection of the uterus is a common and
costly cause of disease and infertility in humans and
domestic animals. Dairy cows appear to have a
particular propensity for uterine disease after parturi-
tion, with up to 40% of animals affected.2 Uterine
disease and other systemic diseases are associated
with perturbation of ovarian follicle function in cat-
tle.7,44,45 In metritis, the most important pathogen is
E. coli.8,10 Many of the effects of E. coli in disease
processes are mediated via the endotoxin, LPS, or by
cytokines such as TNFa associated with the inflam-
mation that occurs during infection.9 These products
are found in the peripheral plasma and ovarian fol-
licular fluid during uterine infection.6,8,10,12
Ovarian follicle growth and function are character-
ized by secretion of estradiol which is produced in
the ovary by granulosa cell aromatisation of theca-
derived androstenedione.24 Estradiol regulates two
positive feedback loops to maintain the dominant
follicle and induce ovulation. At ovarian level, estra-
diol enhances gonadotropic induction of LH recep-
tors and more FSH receptors in granulosa cells and
in synergy with FSH, increases its own production
by stimulating aromatase activity and the expres-
sion of its own receptors in granulosa and theca
cells.46–49 At pituitary level, estradiol secreted by the
dominant follicle feeds back in the absence of pro-
gesterone to enhance gonadotropin secretion, thus
ensuring the pre-ovulatory LH surge which induces
ovulation.50
The cell surface receptor that mediates most of
the effects of LPS is Toll-like receptor 4 (TLR4) in
association with CD14 and MD-2,9,27 and this
receptor complex is present in the ovary of mice
and cattle.12,51 In this study, estradiol production
by granulosa cells in an immune cell-free culture
was inhibited in response to LPS, despite FSH and
androstenedione concentrations remaining constant.
Furthermore, in the theca cell cultures where LH
remained constant, androstenedione production did
not change in response to LPS. Together these
results indicate that rather than affecting pituitary
FSH production or secretion, LPS reduces the abil-
ity of granulosa cells to respond to FSH or to aro-
matize androstenedione to estradiol. Similarly, in
the rat, LPS decreases the LH-induced aromatiza-
tion of androgens to oestrogen resulting in an
inhibition of estradiol production.52 Following
48-hr LPS treatment, no difference was seen in LH
receptor expression of bovine granulosa cells12;
alternatively, a dose-dependant decrease in LH
receptor formation was observed in rat granulosa
cells treated with LPS. It could be postulated that
longer exposure to LPS reduces LH receptors on
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granulosa cells thus inhibiting the response to LH
and thereby blocking ovulation. This may explain
why, in this study, animals treated with LPS failed
to ovulate in the presence of normal LH concen-
trations, although further work is required to vali-
date this.
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diameter, and (b) plasma estradiol concentra-
tions, for control ( ) and treated (h) animals
infused with (i) LPS (n = 8 per treatment) or
(ii) TNFa (n = 7 per treatment).
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It is well established that granulosa cells have
receptors for TNFa.53–55 Estradiol secretion is sup-
pressed following treatment of granulosa cells with
TNFa in the rat and human52,53; and the expression
of 17bHSD and P450arom mRNA is decreased.56 In
the cow, FSH-induced estradiol production in granu-
losa cells from small follicles, and LH-induced andro-
stenedione production by theca cells from large
follicles, are both inhibited following treatment with
TNFa.19 In this study, TNFa treatment also inhibited
FSH-induced estradiol production by bovine granu-
losa cells from small, medium, and large follicles.
Furthermore, LH-induced androstenedione produc-
tion by cells from small, medium and large follicles
was also inhibited. This inhibition of ovarian cell ste-
roidogenesis was observed 96-hr after treatment;
thus, the results of this study suggest that it may be
prolonged exposure to TNFa, which results in
decreased steroidogenic function of these cells.
Infusion of LPS into the uterine lumen blunted the
pre-ovulatory LH surge in heifers leading to failure of
ovulation and the formation of cystic follicles.43
Administration of LPS intravenously results in the
disruption of neuroendocrine activity and interfer-
ence with the oestrous cycle of sheep. Hypothalamic
GnRH secretion is suppressed, pulsatile LH secretion
from the pituitary is inhibited and there is a reduc-
tion in pituitary responsiveness to GnRH.16 However,
these effects are seen at concentrations of LPS, which
induce systemic illness in the animals treated. In con-
trast to these previous studies, a feature of this study
was the administration of treatment at concentra-
tions, which do not cause systemic sickness in the
animals. Indeed, the animals were clinically normal;
rectal temperature and acute phase protein concen-
trations were in the normal range. Furthermore,
there was no evidence that LPS or TNFa affected the
secretion of LH allowing the direct effect on the
ovary to be evaluated. Thus, our results provide evi-
dence of a direct utero-ovarian pathway via which
LPS or TNFa directly modulate ovarian function. The
in vivo responses were subtle perhaps because of the
limited systemic effect. However, treatment was asso-
ciated with fewer ovulations even in the face of nor-
mal LH pulse profiles, as observed in sheep.16
Smaller ovulatory follicles result in less effective
luteal structures;57 however, in this study, the CL that
was affected by LPS or TNFa developed from a follicle,
which ovulated prior to treatment. This suggests that
LPS or TNFa may affect luteal cells directly. Indeed,
TNFa has recently been shown to play bifunctional
roles in the regulation of CL function during the oes-
trus cycle.58 In heifers infused with TNFa, peak pro-
gesterone concentrations tended to be lower,
although differences were not significant. Receptors
Table I Pulsatile LH data for heifers infused in utero with LPS or control
LPS treatment
Mean LH
concentration
(ng ⁄mL)
Maximum
LH concentration
(ng ⁄mL)
Minimum LH
concentration
(ng ⁄mL)
Number of
pulses per
480 min
Pulse
amplitude
Pulse
length
Pulse
frequency
Inter-pulse
interval
Control 0.7 ± 0.1 1.5 ± 0.2 0.3 ± 0.2 8.4 ± 1.1 0.6 ± 0.1 28.3 ± 2.5 0.02 ± 0.0 57.1 ± 6.4
LPS treated 0.7 ± 0.1 1.2 ± 0.1 0.3 ± 0.1 7.3 ± 1.3 0.4 ± 0.0 22.9 ± 3.2 0.02 ± 0.0 58.4 ± 7.2
LPS, lipopolysaccharide; TNFa, tumour necrosis factor alpha; LH, luteinising hormone
Values are mean ± S.E.M.
0.0
0.5
1.0
1.5
2.0
(a)
(b)
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41
Pl
as
m
a 
LH
 c
on
ce
nt
ra
tio
n 
(ng
/m
L)
0.0
0.5
1.0
1.5
2.0
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41
Day of infusion
Fig. 6 Representative peripheral plasma LH concentration profiles for
an animal infused with (a) control or (b) LPS.
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for TNFa are present in the bovine CL and low con-
centrations of TNFa similar to those used in this study,
cause luteolysis.58,59 Additionally, TNFa stimulates
the release of PGF2a from CL cells and also endome-
trial cells, which may also result in luteolysis.58 There-
fore, intrauterine infusion of TNFa may affect
progesterone production directly via actions on luteal
cells or indirectly via the induction of prostaglandin
synthesis in the bovine endometrium and CL.
In conclusion, ovarian cell steroidogenesis was
decreased by treatment with LPS or TNFa in vitro.
Granulosa cell estradiol secretion was reduced by
LPS treatment, whilst TNFa reduced theca and gran-
ulosa cells androstenedione and estradiol production,
respectively. Although the effects of LPS or TNFa on
ovarian structures and steroidogenesis were more
subtle in vivo, ovulation of the dominant follicle was
less likely than in control animals. The response was
localized as peripheral immune markers were not
increased and pituitary gonadotropin concentrations
did not differ between treatment groups. Taken
together, this study supports the hypothesis that LPS
or TNFa can directly impact ovarian function. Thus,
it is important to be aware that PID or metritis can
affect ovarian as well as uterine health.
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